Carolin Czauderna

741 total citations
25 papers, 358 citations indexed

About

Carolin Czauderna is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carolin Czauderna has authored 25 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carolin Czauderna's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Carolin Czauderna is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Carolin Czauderna collaborates with scholars based in Germany, United States and Denmark. Carolin Czauderna's co-authors include Jens U. Marquardt, Darko Castven, Friedrich Foerster, Nicola Personeni, Lorenza Rimassa, Peter R. Galle, Bernd Heinrich, Arndt Weinmann, Arndt Vogel and Peter R. Galle and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Carolin Czauderna

25 papers receiving 354 citations

Peers

Carolin Czauderna
Carolin Czauderna
Citations per year, relative to Carolin Czauderna Carolin Czauderna (= 1×) peers Hamza Chettouh

Countries citing papers authored by Carolin Czauderna

Since Specialization
Citations

This map shows the geographic impact of Carolin Czauderna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolin Czauderna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolin Czauderna more than expected).

Fields of papers citing papers by Carolin Czauderna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolin Czauderna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolin Czauderna. The network helps show where Carolin Czauderna may publish in the future.

Co-authorship network of co-authors of Carolin Czauderna

This figure shows the co-authorship network connecting the top 25 collaborators of Carolin Czauderna. A scholar is included among the top collaborators of Carolin Czauderna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolin Czauderna. Carolin Czauderna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagel, Michael, Christian Labenz, Carolin Czauderna, et al.. (2022). Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation. European Journal of Gastroenterology & Hepatology. 34(10). 1053–1059. 3 indexed citations
2.
Czauderna, Carolin, et al.. (2021). Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma. Journal of Clinical Medicine. 10(13). 2803–2803. 12 indexed citations
3.
Czauderna, Carolin, Kim Barbara Luley, Nikolas von Bubnoff, & Jens U. Marquardt. (2021). Tailored Systemic Therapy for Colorectal Cancer Liver Metastases. International Journal of Molecular Sciences. 22(21). 11780–11780. 11 indexed citations
4.
Gairing, Simon Johannes, Carolin Czauderna, Thomas Thomaidis, et al.. (2021). Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer. JHEP Reports. 4(3). 100417–100417. 10 indexed citations
5.
Czauderna, Carolin, Alicia Poplawski, Colm J. O’Rourke, et al.. (2021). Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI Insight. 6(17). 15 indexed citations
6.
Castven, Darko, Carolin Czauderna, Diana Becker, et al.. (2021). Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells. Hepatology Communications. 6(5). 1140–1156. 12 indexed citations
7.
Gairing, Simon Johannes, Lukáš Müller, Felix Hähn, et al.. (2021). The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma. Journal of Clinical Medicine. 10(12). 2732–2732. 7 indexed citations
8.
Rimassa, Lorenza, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, & Peter R. Galle. (2020). Systemic treatment of HCC in special populations. Journal of Hepatology. 74(4). 931–943. 72 indexed citations
9.
Czauderna, Carolin, Marcus Stockinger, Heinz Schmidberger, et al.. (2020). Monozentrische Erfahrungen mit stereotaktischer Bestrahlung (SBRT) beim fortgeschrittenen hepatozellulären Karzinom im Stadium BCLC-C. Zeitschrift für Gastroenterologie. 58(1). 39–47. 1 indexed citations
10.
Heinrich, S., Martin F. Sprinzl, Irene Schmidtmann, et al.. (2020). Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. United European Gastroenterology Journal. 8(4). 444–452. 6 indexed citations
11.
Czauderna, Carolin, Irene Schmidtmann, Sandra Koch, et al.. (2020). High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma. United European Gastroenterology Journal. 9(3). 388–397. 4 indexed citations
12.
Marquardt, Jens U., Anna Saborowski, Carolin Czauderna, & Arndt Vogel. (2019). The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies. Targeted Oncology. 14(2). 115–123. 21 indexed citations
13.
Czauderna, Carolin, Alicia Poplawski, Darko Castven, et al.. (2019). Landscape of (epi-)genetic alterations during malignant transformation in liver cancer. Zeitschrift für Gastroenterologie. 1 indexed citations
14.
Czauderna, Carolin, Alicia Poplawski, Darko Castven, et al.. (2019). THU-453-Dissecting the landscape of (epi-)genetic alterations during sequential evolution of liver cancer. Journal of Hepatology. 70(1). e358–e359. 4 indexed citations
15.
Heinrich, Bernd, Carolin Czauderna, & Jens U. Marquardt. (2018). Immunotherapy of Hepatocellular Carcinoma. Oncology Research and Treatment. 41(5). 292–297. 29 indexed citations
16.
Finkelmeier, Fabian, Carolin Czauderna, Lukas Perkhofer, et al.. (2018). Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers. Journal of Cancer Research and Clinical Oncology. 145(1). 253–259. 37 indexed citations
17.
Czauderna, Carolin, Mayrel Palestino Domínguez, Darko Castven, et al.. (2018). Ginkgo biloba induces different gene expression signatures and oncogenic pathways in malignant and non-malignant cells of the liver. PLoS ONE. 13(12). e0209067–e0209067. 13 indexed citations
18.
Czauderna, Carolin, Lothar R. Pilz, Hauke Lang, et al.. (2018). A high alpha-fetoprotein slope prior to therapy correlates with poor prognosis of patients with hepatocellular carcinomas. Journal of Hepatology. 68. S442–S442. 1 indexed citations
19.
Czauderna, Carolin, Jens U. Marquardt, Peter R. Galle, & Marcus‐Alexander Wörns. (2017). Das hepatozelluläre Karzinom. Der Internist. 58(5). 469–479. 1 indexed citations
20.
Castven, Darko, Michael B. Fischer, Diana Becker, et al.. (2017). Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas. Oncotarget. 8(30). 48688–48700. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026